{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:55:51Z","timestamp":1794081351846,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.anaerobe.2024.102857","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T03:13:55Z","timestamp":1714014835000},"page":"102857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Genotypic and phenotypic antimicrobial resistance of Irish Clostridioides difficile isolates, 2022"],"prefix":"10.1016","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3616-9070","authenticated-orcid":false,"given":"Lieke","family":"Brouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.anaerobe.2024.102857_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.gtc.2021.02.010","article-title":"A review of Clostridioides difficile infection and antibiotic-associated diarrhea","volume":"50","author":"Abad","year":"2021","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.anaerobe.2024.102857_bib2","series-title":"Clostridioides (Clostridium) difficile Infections - Annual Epidemiological Report for 2016-2017","year":"2022"},{"issue":"Suppl 2","key":"10.1016\/j.anaerobe.2024.102857_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.anaerobe.2024.102857_bib5","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2024.102857_bib6","series-title":"Clostridioides difficile Infection: Antimicrobial Prescribing","year":"2021"},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/jac\/dkt302","article-title":"In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin","volume":"69","author":"Leeds","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10096-019-03708-7","article-title":"Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study","volume":"39","author":"Freeman","year":"2020","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13756-020-00815-5","article-title":"Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis","volume":"9","author":"Sholeh","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"issue":"7","key":"10.1016\/j.anaerobe.2024.102857_bib10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/JCM.02250-16","article-title":"Update on antimicrobial resistance in Clostridium difficile: resistance mechanisms and antimicrobial susceptibility testing","volume":"55","author":"Peng","year":"2017","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"10.1016\/j.anaerobe.2024.102857_bib11","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/jac\/dkab097","article-title":"Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile","volume":"76","author":"Boekhoud","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2024.102857_bib12","series-title":"Clinical Breakpoints and Dosing of Antibiotic","year":"2022"},{"key":"10.1016\/j.anaerobe.2024.102857_bib13","series-title":"M100 Performance Standards for Antimicrobial Susceptibility Testing","year":"2022"},{"key":"10.1016\/j.anaerobe.2024.102857_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8414257","article-title":"Clostridium difficile infections: a global overview of drug sensitivity and resistance mechanisms","volume":"2018","author":"Banawas","year":"2018","journal-title":"BioMed Res. Int."},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2022.2150452","article-title":"Pathogenicity and virulence of Clostridioides difficile","volume":"14","author":"Buddle","year":"2023","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.anaerobe.2024.102857_bib16","article-title":"Genetic mechanisms of vancomycin resistance in Clostridioides difficile: a systematic review","volume":"11","author":"Eubank","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"11","key":"10.1016\/j.anaerobe.2024.102857_bib17","article-title":"A species-wide genetic atlas of antimicrobial resistance in Clostridioides difficile","volume":"7","author":"Imwattana","year":"2021","journal-title":"Microb. Genom."},{"key":"10.1016\/j.anaerobe.2024.102857_bib18","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3389\/fmicb.2018.02994","article-title":"Genomic study of a Clostridium difficile multidrug resistant outbreak-related clone reveals novel determinants of resistance","volume":"9","author":"Isidro","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.anaerobe.2024.102857_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3201\/eid2404.170095","article-title":"Imipenem resistance in Clostridium difficile ribotype 017, Portugal","volume":"24","author":"Isidro","year":"2018","journal-title":"Emerg. Infect. Dis."},{"issue":"11","key":"10.1016\/j.anaerobe.2024.102857_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens11111310","article-title":"Detection and genomic characterisation of Clostridioides difficile from spinach fields","volume":"11","author":"Marcos","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib21","first-page":"23","article-title":"Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection","volume":"3","author":"Spigaglia","year":"2016","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"25","key":"10.1016\/j.anaerobe.2024.102857_bib22","article-title":"Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltim.)"},{"issue":"12","key":"10.1016\/j.anaerobe.2024.102857_bib23","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/jac\/dkab231","article-title":"Mechanisms of antibiotic resistance of Clostridioides difficile","volume":"76","author":"Wickramage","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.anaerobe.2024.102857_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/dkz513","article-title":"Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates","volume":"75","author":"Shen","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.anaerobe.2024.102857_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10096-014-2290-9","article-title":"Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from a university teaching hospital in Japan","volume":"34","author":"Kuwata","year":"2015","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"7","key":"10.1016\/j.anaerobe.2024.102857_bib27","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1128\/AAC.00191-12","article-title":"Characterizations of clinical isolates of Clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan","volume":"56","author":"Liao","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt 6","key":"10.1016\/j.anaerobe.2024.102857_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1099\/jmm.0.47738-0","article-title":"Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe","volume":"57","author":"Spigaglia","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2024.102857_bib29","unstructured":"European Committee on Anitmicrobial Susceptibility Testing (EUCAST). MIC and zone distributions and ECOFFs. [cited 2024 January]; Available from: https:\/\/www.eucast.org\/mic_and_zone_distributions_and_ecoffs."},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01322-21","article-title":"Whole-genome sequencing reveals the high nosocomial transmission and antimicrobial resistance of Clostridioides difficile in a single center in China, a four-year retrospective study","volume":"10","author":"Wen","year":"2022","journal-title":"Microbiol. Spectr."},{"issue":"6","key":"10.1016\/j.anaerobe.2024.102857_bib31","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3855\/jidc.16056","article-title":"Molecular epidemiology and antimicrobial resistance patterns of Clostridioides difficile isolates in Algerian hospitals","volume":"16","author":"Boudjelal","year":"2022","journal-title":"J. Infect. Dev. Ctrie."},{"key":"10.1016\/j.anaerobe.2024.102857_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2020.102290","article-title":"Genomic basis of antimicrobial resistance in non-toxigenic Clostridium difficile in Southeast Asia","volume":"66","author":"Imwattana","year":"2020","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.anaerobe.2024.102857_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/cid\/ciu395","article-title":"Antimicrobial resistance and susceptibility testing of anaerobic bacteria","volume":"59","author":"Schuetz","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.anaerobe.2024.102857_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.anaerobe.2017.10.002","article-title":"Rifaximin-resistant Clostridium difficile strains isolated from symptomatic patients","volume":"48","author":"Reigadas","year":"2017","journal-title":"Anaerobe"},{"issue":"4","key":"10.1016\/j.anaerobe.2024.102857_bib35","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/JCM.02209-10","article-title":"Diagnostic accuracy assessment of Sensititre and agar disk diffusion for determining antimicrobial resistance profiles of bovine clinical mastitis pathogens","volume":"49","author":"Saini","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.anaerobe.2024.102857_bib36","series-title":"Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria","first-page":"M11","year":"2018"},{"issue":"3","key":"10.1016\/j.anaerobe.2024.102857_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/mdr.2004.10.191","article-title":"CdeA of Clostridium difficile, a new multidrug efflux transporter of the MATE family","volume":"10","author":"Dridi","year":"2004","journal-title":"Microb. Drug Resist."},{"issue":"1","key":"10.1016\/j.anaerobe.2024.102857_bib38","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1038\/s41598-017-10155-x","article-title":"CD2068 potentially mediates multidrug efflux in Clostridium difficile","volume":"7","author":"Ngernsombat","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.anaerobe.2024.102857_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00415-20","article-title":"Chromosomal resistance to metronidazole in Clostridioides difficile can be mediated by epistasis between iron homeostasis and oxidoreductases","volume":"64","author":"Deshpande","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.anaerobe.2024.102857_bib40","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s40121-021-00426-6","article-title":"Global landscape of Clostridioides difficile phylogeography, antibiotic susceptibility, and toxin polymorphisms by post-hoc whole-genome sequencing from the MODIFY I\/II studies","volume":"10","author":"Zhao","year":"2021","journal-title":"Infect. Dis. Ther."},{"issue":"3","key":"10.1016\/j.anaerobe.2024.102857_bib41","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.gastro.2020.10.046","article-title":"Plasmid acquisition alters vancomycin susceptibility in Clostridioides difficile","volume":"160","author":"Pu","year":"2021","journal-title":"Gastroenterology"}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996424000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996424000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T23:22:38Z","timestamp":1724455358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996424000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":39,"alternative-id":["S1075996424000404"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2024.102857","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotypic and phenotypic antimicrobial resistance of Irish Clostridioides difficile isolates, 2022","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2024.102857","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102857"}}